Effect of LMO2 protein expression on survival in chronic myeloid leukemia patients treated with imatinib mesylate

By Sonmez Mehmet   Akagun Tulin   Cobanoglu Umit   Topbas Murat   Erkut Nergiz   Yilmaz Mustafa   Ovali Ercument   Omay Serdar Bedii  

Hematology, Vol. 14, Iss. 4, 2009-08 ,pp. : 220-223

Maney Publishing

Access to resources Recommend Favorite

CD20 expression in B-cell precursor acute lymphoblastic leukemia is common in Mexican patients and lacks a prognostic value

By Solano-Genesta Manuel   Tarín-Arzaga Luz   Velasco-Ruiz Ileana   Lutz-Presno Julia A.   González-Llano Oscar   Mancías-Guerra Consuelo   Rodríguez-Romo Laura   Ruiz-Delgado Guillermo J.   Ruiz-Argüelles Guillermo J.   Jaime-Pérez José Carlos   Gómez-Almaguer David  

Hematology, Vol. 17, Iss. 2, 2012-03 ,pp. : 66-70

Maney Publishing

Access to resources Recommend Favorite

Prognostic significance of Bcell lymphoma 2 expression in acute leukemia: A systematic review and metaanalysis

By                  

Molecular and Clinical Oncology, Vol. 2, Iss. 3, 2014-01 ,pp. : 411-414

Spandidos Publications

Access to resources Recommend Favorite

Molecular evidence for transferrin receptor 2 expression in all FAB subtypes of acute myeloid leukemia

By Kollia P.   Samara M.   Stamatopoulos K.   Belessi C.   Stavroyianni N.   Tsompanakou A.   Athanasiadou A.   Vamvakopoulos N.   Laoutaris N.   Anagnostopoulos A.   Fassas A.  

Leukemia Research, Vol. 27, Iss. 12, 2003-12 ,pp. : 1101-1103

Elsevier

Access to resources Recommend Favorite

Expression and prognostic value of FAS receptor/FAS ligand and TrailR1/TrailR2 in acute myeloid leukemia

By Pordzik Sandra   Petrovici Karin   Schmid Christoph   Kroell Tanja   Schweiger Cornelia   Köhne Claus-Henning   Schmetzer Helga  

Hematology, Vol. 16, Iss. 6, 2011-11 ,pp. : 341-350

Maney Publishing

Access to resources Recommend Favorite